Vimarsana
Biggest News Aggregation in the World

Page 5 - Societal Cdmo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Societal Cdmo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Societal Cdmo Today - Breaking & Trending Today

Societal CDMO Announces Proposed Public Offering of Common - Vimarsana News

Societal CDMO Announces Proposed Public Offering of Common

SAN DIEGO and GAINESVILLE, Ga., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and...

Societal CDMO : Failure to Satisfy Listing Rule - Form 8-K - Vimarsana News

Societal CDMO : Failure to Satisfy Listing Rule - Form 8-K

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to... | May 27, 2023

Societal CDMO, Inc. (NASDAQ:SCTL) Q1 2023 Earnings Call Transcript - Vimarsana News

Societal CDMO, Inc. (NASDAQ:SCTL) Q1 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to the Societal CDMO First Quarter 2023 Financial Results Conference Call. [Operator Instructions].

Cowen Prime Advisors LLC Acquires 1,103,000 Shares of Societal CDMO, Inc. (NASDAQ:SCTL) - Vimarsana News

Cowen Prime Advisors LLC Acquires 1,103,000 Shares of Societal CDMO, Inc. (NASDAQ:SCTL)

Cowen Prime Advisors LLC lifted its holdings in shares of Societal CDMO, Inc. (NASDAQ:SCTL – Get Rating) by 34.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,312,400 shares of the company’s stock after acquiring an additional 1,103,000 shares during the period. Societal CDMO accounts […]

Source: wkrb13.com
Societal CDMO Selected by Longboard Pharmaceuticals to - Vimarsana News

Societal CDMO Selected by Longboard Pharmaceuticals to

CDMO Services Focused on Longboard’s Oral, Centrally Acting 5-HT2C Receptor Superagonist, Being Developed for the Potential Treatment of Refractory...